The higher number of cancer may be called 'anomaly' because ezitimibe doesn't show potential to damage DNA or other 'pro cancer' properties. The only way to close the issue is longer observational studies (like the Nurses' Health Study I and II studies) with more than 40,000 people.
The State of Statins and Stents [View article]